{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:48:34Z","timestamp":1788576514520,"version":"build-2803163510"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T00:00:00Z","timestamp":1536710400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Merck Sharpe & Dohme"},{"name":"Fonds de Recherche du Qu\u00e9bec en sant\u00e9"},{"name":"CIHR-Huntington Society of Canada postdoctoral fellowship"},{"name":"National Institute for Health Research award"},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015569","name":"Canadian Consortium on Neurodegeneration in Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Desjardins scholarship from the Fondation du CHU de Qu\u00e9bec"},{"name":"Excellence scholarship from the Centre Th\u00e9matique de Recherche en Neurosciences (CTRN) du CHU de Qu\u00e9bec."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00415-018-9022-5","type":"journal-article","created":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T05:23:08Z","timestamp":1536729788000},"page":"2704-2712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Platelet-derived extracellular vesicles in Huntington\u2019s disease"],"prefix":"10.1007","volume":"265","author":[{"given":"H\u00e9l\u00e8na L.","family":"Denis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Lamontagne-Proulx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"St-Amour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Chouinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boilard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,12]]},"reference":[{"key":"9022_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/ana.410100107","volume":"10","author":"BV Manyam","year":"1981","unstructured":"Manyam BV, Katz L, Hare TA et al (1981) Isoniazid-induced elevation of CSF GABA levels and effects on chorea in Huntington\u2019s disease. Ann Neurol 10:35\u201337. \n                    https:\/\/doi.org\/10.1002\/ana.410100107","journal-title":"Ann Neurol"},{"key":"9022_CR2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/0024-3205(80)90089-2","volume":"26","author":"NV Manyam","year":"1980","unstructured":"Manyam NV, Hare TA, Katz L (1980) Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington\u2019s disease. Life Sci 26:1303\u20131308. \n                    https:\/\/doi.org\/10.1016\/0024-3205(80)90089-2","journal-title":"Life Sci"},{"key":"9022_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/jhd-130049","volume":"2","author":"E Silajdzic","year":"2013","unstructured":"Silajdzic E, Rezeli M, Vegvari A et al (2013) A critical evaluation of inflammatory markers in Huntington\u2019s disease plasma. J Huntingt Dis 2:125\u2013134. \n                    https:\/\/doi.org\/10.3233\/jhd-130049","journal-title":"J Huntingt Dis"},{"key":"9022_CR4","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bj\u00f6rkqvist","year":"2008","unstructured":"Bj\u00f6rkqvist M, Wild EJ, Thiele J et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205:1869\u20131877. \n                    https:\/\/doi.org\/10.1084\/jem.20080178","journal-title":"J Exp Med"},{"key":"9022_CR5","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1021\/ci970236v","volume":"37","author":"NN Aronson","year":"1997","unstructured":"Aronson NN, Blanchard CJ, Madura JD (1997) Homology modeling of glycosyl hydrolase family 18 enzymes and proteins. J Chem Inf Comput Sci 37:999\u20131005.\u00a0\n                    https:\/\/doi.org\/10.1021\/ci970236v","journal-title":"J Chem Inf Comput Sci"},{"key":"9022_CR6","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.parkreldis.2014.08.011","volume":"20","author":"T Vinther-Jensen","year":"2014","unstructured":"Vinther-Jensen T, Budtz-Jorgensen E, Simonsen AH et al (2014) YKL-40 in cerebrospinal fluid in Huntington\u2019s disease\u2014a role in pathology or a nonspecific response to inflammation? Parkinsonism Relat Disord 20:1301\u20131303. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2014.08.011","journal-title":"Parkinsonism Relat Disord"},{"key":"9022_CR7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neubiorev.2013.01.022","volume":"37","author":"N Georgiou-Karistianis","year":"2013","unstructured":"Georgiou-Karistianis N, Scahill R, Tabrizi SJ et al (2013) Structural MRI in Huntington\u2019s disease and recommendations for its potential use in clinical trials. Neurosci Biobehav Rev 37:480\u2013490. \n                    https:\/\/doi.org\/10.1016\/j.neubiorev.2013.01.022","journal-title":"Neurosci Biobehav Rev"},{"key":"9022_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/hbm.22019","volume":"34","author":"C Sanchez-Castaneda","year":"2013","unstructured":"Sanchez-Castaneda C, Cherubini A, Elifani F et al (2013) Seeking Huntington disease biomarkers by multimodal, cross-sectional basal ganglia imaging. Hum Brain Mapp 34:1625\u20131635. \n                    https:\/\/doi.org\/10.1002\/hbm.22019","journal-title":"Hum Brain Mapp"},{"key":"9022_CR9","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0006-291X(80)80121-5","volume":"95","author":"WA Bialas","year":"1980","unstructured":"Bialas WA, Markesbery WR, Butterfield DA (1980) Increased chloride transport in erythrocytes in Huntington\u2019s disease. Biochem Biophys Res Commun 95:1895\u20131900.\u00a0\n                    https:\/\/doi.org\/10.1016\/S0006-291X(80)80121-5","journal-title":"Biochem Biophys Res Commun"},{"key":"9022_CR10","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"C-M Chen","year":"2007","unstructured":"Chen C-M, Wu Y-R, Cheng M-L et al (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Commun 359:335\u2013340. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2007.05.093","journal-title":"Biochem Biophys Res Commun"},{"key":"9022_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000115988","volume":"25","author":"PH Kraus","year":"1986","unstructured":"Kraus PH, Vigenschow H, Przuntek H (1986) Spin label study of red blood cell membranes in Huntington\u2019s disease. Eur Neurol 25:61\u201366. \n                    https:\/\/doi.org\/10.1159\/000115988","journal-title":"Eur Neurol"},{"key":"9022_CR12","first-page":"71","volume":"36","author":"SF Zakharov","year":"1990","unstructured":"Zakharov SF, Shandala AM, Shcheglova MV et al (1990) Comparative study of human erythrocyte membranes in normal people and in Huntington\u2019s chorea patients. Vopr Med Khim 36:71\u201373","journal-title":"Vopr Med Khim"},{"key":"9022_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.coph.2015.09.008","volume":"26","author":"R Andre","year":"2016","unstructured":"Andre R, Carty L, Tabrizi SJ (2016) Disruption of immune cell function by mutant huntingtin in Huntington\u2019s disease pathogenesis. Curr Opin Pharmacol 26:33\u201338. \n                    https:\/\/doi.org\/10.1016\/j.coph.2015.09.008","journal-title":"Curr Opin Pharmacol"},{"key":"9022_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jnutbio.2015.12.001","volume":"31","author":"M-L Cheng","year":"2016","unstructured":"Cheng M-L, Chang K-H, Wu Y-R, Chen C-M (2016) Metabolic disturbances in plasma as biomarkers for Huntington\u2019s disease. J Nutr Biochem 31:38\u201344. \n                    https:\/\/doi.org\/10.1016\/j.jnutbio.2015.12.001","journal-title":"J Nutr Biochem"},{"key":"9022_CR15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1007\/s12035-015-9147-9","volume":"53","author":"KL Narayanan","year":"2016","unstructured":"Narayanan KL, Chopra V, Rosas HD et al (2016) Rho kinase pathway alterations in the brain and leukocytes in Huntington\u2019s disease. Mol Neurobiol 53:2132\u20132140. \n                    https:\/\/doi.org\/10.1007\/s12035-015-9147-9","journal-title":"Mol Neurobiol"},{"key":"9022_CR16","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/brain\/awt355","volume":"137","author":"U Tr\u00e4ger","year":"2014","unstructured":"Tr\u00e4ger U, Andre R, Lahiri N et al (2014) HTT-lowering reverses Huntington\u2019s disease immune dysfunction caused by NF\u03baB pathway dysregulation. Brain 137:819\u2013833. \n                    https:\/\/doi.org\/10.1093\/brain\/awt355","journal-title":"Brain"},{"key":"9022_CR17","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1096\/fj.03-0079fje","volume":"17","author":"K Varani","year":"2003","unstructured":"Varani K, Abbracchio MP, Cannella M et al (2003) Aberrant A2A receptor function in peripheral blood cells in Huntington\u2019s disease. FASEB J 17:2148\u20132150. \n                    https:\/\/doi.org\/10.1096\/fj.03-0079fje","journal-title":"FASEB J"},{"key":"9022_CR18","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1172\/jci64565","volume":"122","author":"A Weiss","year":"2012","unstructured":"Weiss A, Trager U, Wild EJ et al (2012) Mutant huntingtin fragmentation in immune cells tracks Huntington\u2019s disease progression. J Clin Investig 122:3731\u20133736. \n                    https:\/\/doi.org\/10.1172\/jci64565","journal-title":"J Clin Investig"},{"key":"9022_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0140-6736(74)90873-3","volume":"2","author":"MJ Aminoff","year":"1974","unstructured":"Aminoff MJ, Trenchard A, Turner P et al (1974) Plasma uptake of dopamine and 5-hydroxytryptamine and plasma-catecholamine levels in patients with Huntington\u2019s chorea. Lancet 2:1115\u20131116.\u00a0\n                    https:\/\/doi.org\/10.1016\/S0140-6736(74)90873-3","journal-title":"Lancet"},{"key":"9022_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0364-7722(80)90048-X","volume":"4","author":"M Diez-Ewald","year":"1980","unstructured":"Diez-Ewald M, Bonilla E, Gonzalez JV (1980) Platelet aggregation, 5-hydroxytryptamine uptake and release in Huntington\u2019s chorea. Prog Neuropsychopharmacol Biol Psychiatry 4:277\u2013283","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9022_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM et al (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389. \n                    https:\/\/doi.org\/10.1002\/ana.410390317","journal-title":"Ann Neurol"},{"key":"9022_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neulet.2005.09.037","volume":"393","author":"V Maglione","year":"2006","unstructured":"Maglione V, Cannella M, Martino T et al (2006) The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington\u2019s disease patients with predominant chorea. Neurosci Lett 393:27\u201330. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2005.09.037","journal-title":"Neurosci Lett"},{"key":"9022_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00702-003-0103-x","volume":"111","author":"M Markianos","year":"2004","unstructured":"Markianos M, Panas M, Kalfakis N, Vassilopoulos D (2004) Platelet monoamine oxidase activity in subjects tested for Huntington\u2019s disease gene mutation. J Neural Transm 111:475\u2013483. \n                    https:\/\/doi.org\/10.1007\/s00702-003-0103-x","journal-title":"J Neural Transm"},{"key":"9022_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/BF02141780","volume":"232","author":"Y Muramatsu","year":"1982","unstructured":"Muramatsu Y, Kaiya H, Imai H et al (1982) Abnormal platelet aggregation response in Huntington\u2019s disease. Arch Psychiatry Neurol Sci (1970) 232:191\u2013200.\u00a0\n                    https:\/\/doi.org\/10.1007\/BF02141780","journal-title":"Arch Psychiatry Neurol Scie (1970)"},{"key":"9022_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0022-510X(94)90134-1","volume":"127","author":"R Reilmann","year":"1994","unstructured":"Reilmann R, Rolf LH, Lange HW (1994) Huntington\u2019s disease: the neuroexcitotoxin aspartate is increased in platelets and decreased in plasma. J Neurol Sci 127:48\u201353.\u00a0\n                    https:\/\/doi.org\/10.1016\/0022-510X(94)90134-1","journal-title":"J Neurol Sci"},{"key":"9022_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","volume":"13","author":"AC Silva","year":"2013","unstructured":"Silva AC, Almeida S, La\u00e7o M et al (2013) Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington\u2019s disease carriers. Mitochondrion 13:801\u2013809. \n                    https:\/\/doi.org\/10.1016\/j.mito.2013.05.006","journal-title":"Mitochondrion"},{"key":"9022_CR27","first-page":"116","volume":"59","author":"E Tukiainen","year":"1981","unstructured":"Tukiainen E, Wikstr\u00f6m J, Kilpel\u00e4inen H (1981) Uptake of 5-hydroxytryptamine by blood platelets in Huntington\u2019s chorea and Alzheimer type of presenile dementia. Med Biol 59:116\u2013120","journal-title":"Med Biol"},{"key":"9022_CR28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.bbalip.2014.12.018","volume":"1851","author":"V Leoni","year":"2015","unstructured":"Leoni V, Caccia C (2015) The impairment of cholesterol metabolism in Huntington disease. Biochem Biophys Acta 1851:1095\u20131105. \n                    https:\/\/doi.org\/10.1016\/j.bbalip.2014.12.018","journal-title":"Biochem Biophys Acta"},{"key":"9022_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","volume":"395","author":"A Weiss","year":"2009","unstructured":"Weiss A, Abramowski D, Bibel M et al (2009) Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington\u2019s disease. Anal Biochem 395:8\u201315. \n                    https:\/\/doi.org\/10.1016\/j.ab.2009.08.001","journal-title":"Anal Biochem"},{"key":"9022_CR30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/brain\/awm312","volume":"131","author":"AN Anderson","year":"2008","unstructured":"Anderson AN, Roncaroli F, Hodges A et al (2008) Chromosomal profiles of gene expression in Huntington\u2019s disease. Brain 131:381\u2013388. \n                    https:\/\/doi.org\/10.1093\/brain\/awm312","journal-title":"Brain"},{"key":"9022_CR31","doi-asserted-by":"publisher","first-page":"11023","DOI":"10.1073\/pnas.0504921102","volume":"102","author":"F Borovecki","year":"2005","unstructured":"Borovecki F, Lovrecic L, Zhou J et al (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington\u2019s disease. Proc Natl Acad Sci 102:11023\u201311028. \n                    https:\/\/doi.org\/10.1073\/pnas.0504921102","journal-title":"Proc Natl Acad Sci"},{"key":"9022_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/jnnp.2010.208264","volume":"82","author":"EH Aylward","year":"2011","unstructured":"Aylward EH, Nopoulos PC, Ross CA et al (2011) Longitudinal change in regional brain volumes in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 82:405\u2013410. \n                    https:\/\/doi.org\/10.1136\/jnnp.2010.208264","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9022_CR33","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11682-011-9121-8","volume":"5","author":"I Bohanna","year":"2011","unstructured":"Bohanna I, Georgiou-Karistianis N, Sritharan A et al (2011) Diffusion tensor imaging in Huntington\u2019s disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging Behav 5:171\u2013180. \n                    https:\/\/doi.org\/10.1007\/s11682-011-9121-8","journal-title":"Brain Imaging Behav"},{"key":"9022_CR34","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/S0140-6736(94)92987-4","volume":"343","author":"CA Davie","year":"1994","unstructured":"Davie CA, Barker GJ, Quinn N et al (1994) Proton MRS in Huntington\u2019s disease. Lancet 343:1580. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(94)92987-4","journal-title":"Lancet"},{"key":"9022_CR35","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1212\/WNL.50.5.1357","volume":"50","author":"BG Jenkins","year":"1998","unstructured":"Jenkins BG, Rosas HD, Chen YC et al (1998) 1H NMR spectroscopy studies of Huntington\u2019s disease: correlations with CAG repeat numbers. Neurology 50:1357\u20131365","journal-title":"Neurology"},{"key":"9022_CR36","first-page":"1715","volume":"25","author":"JS Paulsen","year":"2004","unstructured":"Paulsen JS, Zimbelman JL, Hinton SC et al (2004) fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington\u2019s disease. Am J Neuroradiol 25:1715\u20131721","journal-title":"Am J Neuroradiol"},{"key":"9022_CR37","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archneurol.2011.2945","volume":"69","author":"HD Rosas","year":"2012","unstructured":"Rosas HD, Chen YI, Doros G et al (2012)\u00a0Alterations in brain transition metals in Huntington\u00a0disease: an evolving and intricate story. Arch Neurol 69:887\u2013893. \n                    https:\/\/doi.org\/10.1001\/archneurol.2011.2945","journal-title":"Arch Neurol"},{"key":"9022_CR38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","volume":"79","author":"HH Ruocco","year":"2008","unstructured":"Ruocco HH, Bonilha L, Li LM et al (2008) Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry 79:130\u2013135. \n                    https:\/\/doi.org\/10.1136\/jnnp.2007.116244","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9022_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3988\/jcn.2013.9.1.21","volume":"9","author":"H Shin","year":"2013","unstructured":"Shin H, Kim MH, Lee SJ et al (2013) Decreased metabolism in the cerebral cortex in early-stage Huntington\u2019s disease: a possible biomarker of disease progression? J Clin Neurosci 9:21\u201325. \n                    https:\/\/doi.org\/10.3988\/jcn.2013.9.1.21","journal-title":"J Clin Neurosci"},{"key":"9022_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jnnp.2007.142786","volume":"81","author":"A Sritharan","year":"2010","unstructured":"Sritharan A, Egan GF, Johnston L et al (2010) A longitudinal diffusion tensor imaging study in symptomatic Huntington\u2019s disease. J Neurol Neurosurg Psychiatry 81:257\u2013262. \n                    https:\/\/doi.org\/10.1136\/jnnp.2007.142786","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9022_CR41","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","volume":"75","author":"A Sturrock","year":"2010","unstructured":"Sturrock A, Laule C, Decolongon J et al (2010) Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology 75:1702\u20131710. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc27e4","journal-title":"Neurology"},{"key":"9022_CR42","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1084\/jem.20160776","volume":"213","author":"M-H Disatnik","year":"2016","unstructured":"Disatnik M-H, Joshi AU, Saw NL et al (2016) Potential biomarkers to follow the progression and treatment response of Huntington\u2019s disease. J Exp Med 213:2655\u20132669. \n                    https:\/\/doi.org\/10.1084\/jem.20160776","journal-title":"J Exp Med"},{"key":"9022_CR43","first-page":"950","volume":"4","author":"MG Olsson","year":"2012","unstructured":"Olsson MG, Davidsson S, Muhammad ZD et al (2012) Increased levels of hemoglobin and alpha1-microglobulin in Huntington\u2019s disease. Front Biosci (Elite Ed) 4:950\u2013957","journal-title":"Front Biosci (Elite Ed)"},{"key":"9022_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.brainresbull.2007.12.007","volume":"76","author":"NI Wood","year":"2008","unstructured":"Wood NI, Goodman AOG, van der Burg JMM et al (2008) Increased thirst and drinking in Huntington\u2019s disease and the R6\/2 mouse. Brain Res Bull 76:70\u201379. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2007.12.007","journal-title":"Brain Res Bull"},{"key":"9022_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jhd-160196","volume":"5","author":"LM Byrne","year":"2016","unstructured":"Byrne LM, Wild EJ (2016) Cerebrospinal fluid biomarkers for Huntington\u2019s disease. J Huntingt Dis 5:1\u201313. \n                    https:\/\/doi.org\/10.3233\/jhd-160196","journal-title":"J Huntingt Dis"},{"key":"9022_CR46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3969\/j.issn.1673-5374.2012.05.009","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J (2012) Oxidative stress in neurodegenerative diseases. Neural Regener Res 7:376\u2013385. \n                    https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.05.009","journal-title":"Neural Regener Res"},{"key":"9022_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1471-4159.1992.tb09283.x","volume":"58","author":"MC Garrett","year":"1992","unstructured":"Garrett MC, Soares-da-Silva P (1992) Increased cerebrospinal fluid dopamine and 3,4-dihydroxyphenylacetic acid levels in Huntington\u2019s disease: evidence for an overactive dopaminergic brain transmission. J Neurochem 58:101\u2013106.\u00a0\n                    https:\/\/doi.org\/10.1111\/j.1471-4159.1992.tb09283.x","journal-title":"J Neurochem"},{"key":"9022_CR48","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1001\/archneur.1988.00520320071018","volume":"45","author":"R Kurlan","year":"1988","unstructured":"Kurlan R, Caine E, Rubin A et al (1988) Cerebrospinal fluid correlates of depression in Huntington\u2019s disease. Arch Neurol 45:881\u2013883. \n                    https:\/\/doi.org\/10.1001\/archneur.1988.00520320071018","journal-title":"Arch Neurol"},{"key":"9022_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00314742","volume":"237","author":"BV Manyam","year":"1990","unstructured":"Manyam BV, Giacobini E, Colliver JA (1990) Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington\u2019s disease. J Neurol 237:281\u2013284.\u00a0\n                    https:\/\/doi.org\/10.1007\/BF00314742","journal-title":"J Neurol"},{"key":"9022_CR50","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/ene.12750","volume":"22","author":"T Vinther-Jensen","year":"2015","unstructured":"Vinther-Jensen T, Simonsen AH, Budtz-J\u00f8rgensen E et al (2015) Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington\u2019s disease. Eur J Neurol 22:1378\u20131384. \n                    https:\/\/doi.org\/10.1111\/ene.12750","journal-title":"Eur J Neurol"},{"key":"9022_CR51","doi-asserted-by":"publisher","first-page":"e89745","DOI":"10.1371\/journal.pone.0089745","volume":"9","author":"A Carrizzo","year":"2014","unstructured":"Carrizzo A, Di Pardo A, Maglione V et al (2014) Nitric oxide dysregulation in platelets from patients with advanced Huntington disease. PLoS One 9:e89745. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0089745","journal-title":"PLoS One"},{"key":"9022_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(17)30124-2","author":"LM Byrne","year":"2017","unstructured":"Byrne LM, Rodrigues FB, Blennow K et al (2017) Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington\u2019s disease: a retrospective cohort analysis. Lancet Neurol. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(17)30124-2","journal-title":"Lancet Neurol"},{"key":"9022_CR53","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1212\/nxi.0000000000000287","volume":"3","author":"T Vinther-Jensen","year":"2016","unstructured":"Vinther-Jensen T, Bornsen L, Budtz-Jorgensen E et al (2016) Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease. Neurol Neuroimmunol Neuroinflamm 3:e287. \n                    https:\/\/doi.org\/10.1212\/nxi.0000000000000287","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"9022_CR54","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/mp.2015.81","volume":"20","author":"Z Tan","year":"2015","unstructured":"Tan Z, Dai W, van Erp TG et al (2015) Huntington\u2019s disease cerebrospinal fluid seeds aggregation of mutant huntingtin. Mol Psychiatry 20:1286\u20131293. \n                    https:\/\/doi.org\/10.1038\/mp.2015.81","journal-title":"Mol Psychiatry"},{"key":"9022_CR55","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1172\/JCI80743","volume":"125","author":"EJ Wild","year":"2015","unstructured":"Wild EJ, Boggio R, Langbehn D et al (2015) Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington\u2019s disease patients. J Clin Investig 125:1979\u20131986. \n                    https:\/\/doi.org\/10.1172\/JCI80743","journal-title":"J Clin Investig"},{"key":"9022_CR56","doi-asserted-by":"publisher","first-page":"35928","DOI":"10.1038\/srep35928","volume":"6","author":"G Marcoux","year":"2016","unstructured":"Marcoux G, Duchez A-C, Cloutier N et al (2016) Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses. Sci Rep 6:35928. \n                    https:\/\/doi.org\/10.1038\/srep35928","journal-title":"Sci Rep"},{"key":"9022_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jth.13190","volume":"14","author":"E Pol van der","year":"2016","unstructured":"van der Pol E, Boing AN, Gool EL, Nieuwland R (2016) Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J Thromb Haemost JTH 14:48\u201356. \n                    https:\/\/doi.org\/10.1111\/jth.13190","journal-title":"J Thromb Haemost JTH"},{"key":"9022_CR58","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","volume":"68","author":"B Gy\u00f6rgy","year":"2011","unstructured":"Gy\u00f6rgy B, Szab\u00f3 TG, P\u00e1szt\u00f3i M et al (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:2667\u20132688. \n                    https:\/\/doi.org\/10.1007\/s00018-011-0689-3","journal-title":"Cell Mol Life Sci"},{"key":"9022_CR59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrd3978","volume":"12","author":"S Andaloussi","year":"2013","unstructured":"EL Andaloussi S, M\u00e4ger I, Breakefield XO, Wood MJA (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347\u2013357. \n                    https:\/\/doi.org\/10.1038\/nrd3978","journal-title":"Nat Rev Drug Discov"},{"key":"9022_CR60","doi-asserted-by":"publisher","first-page":"26913","DOI":"10.3402\/jev.v3.26913","volume":"3","author":"J L\u00f6tvall","year":"2014","unstructured":"L\u00f6tvall J, Hill AF, Hochberg F et al (2014) Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3:26913.\u00a0\n                    https:\/\/doi.org\/10.3402\/jev.v3.26913","journal-title":"J Extracell Vesicles"},{"key":"9022_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1083\/jcb.201211138","volume":"200","author":"G Raposo","year":"2013","unstructured":"Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373\u2013383. \n                    https:\/\/doi.org\/10.1083\/jcb.201211138","journal-title":"J Cell Biol"},{"key":"9022_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/emmm.201201846","volume":"5","author":"N Cloutier","year":"2013","unstructured":"Cloutier N, Tan S, Boudreau LH et al (2013) The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle-associated immune complexes. EMBO Mol Med 5:235\u2013249. \n                    https:\/\/doi.org\/10.1002\/emmm.201201846","journal-title":"EMBO Mol Med"},{"key":"9022_CR63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1042\/bst20120258","volume":"41","author":"JM Inal","year":"2013","unstructured":"Inal JM, Fairbrother U, Heugh S (2013) Microvesiculation and disease. Biochem Soc Trans 41:237\u2013240. \n                    https:\/\/doi.org\/10.1042\/bst20120258","journal-title":"Biochem Soc Trans"},{"key":"9022_CR64","doi-asserted-by":"crossref","unstructured":"Denis HL, Lamontagne-Proulx J, St-Amour I et al (2018) Platelet abnormalities in Huntington\u2019s disease. J Neurol Neurosurg Psychiatry (in revision)","DOI":"10.1136\/jnnp-2018-318854"},{"key":"9022_CR65","doi-asserted-by":"publisher","first-page":"e0116812","DOI":"10.1371\/journal.pone.0116812","volume":"10","author":"M Rousseau","year":"2015","unstructured":"Rousseau M, Belleannee C, Duchez A-C et al (2015) Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment. PLoS One 10:e0116812. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0116812","journal-title":"PLoS One"},{"key":"9022_CR66","doi-asserted-by":"publisher","first-page":"E3564","DOI":"10.1073\/pnas.1507905112","volume":"112","author":"A-C Duchez","year":"2015","unstructured":"Duchez A-C, Boudreau LH, Naika GS et al (2015) Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA. Proc Natl Acad Sci 112:E3564\u2013E3573. \n                    https:\/\/doi.org\/10.1073\/pnas.1507905112","journal-title":"Proc Natl Acad Sci"},{"key":"9022_CR67","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1182\/blood-2014-05-573543","volume":"124","author":"LH Boudreau","year":"2014","unstructured":"Boudreau LH, Duchez A-C, Cloutier N et al (2014) Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 124:2173\u20132183. \n                    https:\/\/doi.org\/10.1182\/blood-2014-05-573543","journal-title":"Blood"},{"key":"9022_CR68","unstructured":"Lamontagne-Proulx J, St-Amour I, Labib R et al (2018) Erythrocyte-derived extracellular vesicles: a novel, robust and specific biomarker that maps to Parkinson\u2019s disease stages. Neuro Dis\u00a0(Under review)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-9022-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-9022-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T03:02:37Z","timestamp":1589943757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-9022-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,12]]},"references-count":68,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["9022"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-9022-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,12]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}